Word

TRUE CUSTOM

Status

Pending

Status Code

654

Status Date

Tuesday, January 2, 2024

Serial Number

97363649

Mark Type

4000

Filing Date

Thursday, April 14, 2022

Trademark Owner History

Gemini Bioproducts, LLC

Classifications

40 Custom manufacture of compounds and compositions for use in the manufacture of pharmaceuticals by pharmaceutical compounders

5 Biopharmaceutical substances and preparations for human use, including biologic therapies, cell therapies, gene therapies, vaccines, and other biologic therapy modalities, namely, for the treatment of liquid and solid tumor cancers, bone cartilage and joint disease, auto-inflammation diseases, autoimmune diseases, proliferative diseases, endocrine diseases, metabolic diseases, skin diseases, lung diseases, fibrotic diseases, cardiovascular diseases, pain, hepatitis B virus, kidney diseases, osteoporosis, osteoarthritis, rheumatoid arthritis, atopic dermatitis, idiopathic pulmonary fibrosis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, Sjogren's syndrome, lupus, uveitis, scleroderma, non-alcoholic steatohepatitis, polycystic kidney disease, type 2 diabetes

1 Active chemical ingredients for use in the manufacture of pharmaceuticals for treating a wide variety of diseases and medical conditions

42 Custom design and development of compounds and compositions for use in the manufacture of pharmaceuticals

"CUSTOM"

Trademark Events

Jan 2, 2024

Report Completed Suspension Check Case Still Suspended

Apr 22, 2023

Notification Of Letter Of Suspension E-Mailed

Apr 22, 2023

Letter Of Suspension E-Mailed

Apr 22, 2023

Suspension Letter Written

Apr 22, 2023

Teas/Email Correspondence Entered

Apr 21, 2023

Correspondence Received In Law Office

Apr 21, 2023

Teas Response To Office Action Received

Jan 30, 2023

Combined Examiner's Amendment/Priority Action Entered

Jan 30, 2023

Assigned To Lie

Jan 28, 2023

Notification Of Examiner's Amendment/Priority Action E-Mailed

Jan 28, 2023

Examiner's Amendment/Priority Action E-Mailed

Jan 28, 2023

Examiners Amendment And/Or Priority Action - Completed

Dec 31, 2022

Teas/Email Correspondence Entered

Dec 30, 2022

Correspondence Received In Law Office

Dec 30, 2022

Teas Response To Office Action Received

Oct 19, 2022

Notification Of Non-Final Action E-Mailed

Oct 19, 2022

Non-Final Action E-Mailed

Oct 19, 2022

Non-Final Action Written

Oct 7, 2022

Assigned To Examiner

Apr 20, 2022

New Application Office Supplied Data Entered

Apr 18, 2022

New Application Entered